Option Care Health Expects 2024 Sales Of $4.75B-$4.85B Versus Prior Guidance Of $4.65B-$4.80B And Consensus Of $4.753B
Portfolio Pulse from Benzinga Newsdesk
Option Care Health has updated its financial guidance for 2024, expecting net revenue of $4.75 billion to $4.85 billion, adjusted EBITDA of $435 million to $450 million, and cash flow from operations of at least $300 million. The effective tax rate and net interest expense remain consistent with previous guidance.
July 31, 2024 | 11:13 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Option Care Health has raised its 2024 net revenue guidance to $4.75 billion-$4.85 billion, up from the prior $4.65 billion-$4.80 billion. Adjusted EBITDA is expected to be $435 million-$450 million, with cash flow from operations of at least $300 million.
The updated guidance indicates a positive outlook for Option Care Health, with higher expected net revenue and consistent cash flow from operations. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100